Minimally Important Differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument

PURPOSE: To provide minimally important difference (MID) estimates for the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 (UCLA SCTC GIT 2.0) in a longitudinal observational cohort. METHODS: We administered the UCLA SCTC GIT 2.0 to 115 patients with SSc at 2 time points 6 mont...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Khanna, Dinesh, Furst, Daniel E., Maranian, Paul, Seibold, James R., Impens, Ann, Mayes, Maureen D., Clements, Philip J., Getzug, Terri, Hays, Ron D.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3368014/
https://ncbi.nlm.nih.gov/pubmed/21724699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.110225
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars